These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3236647)

  • 21. [Effect of simvastatin on thrombocyte functional activity in patients with ischemic heart disease and hypercholesterinemia].
    Abidova KR
    Lik Sprava; 2004; (3-4):93-7. PubMed ID: 15318838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Various aspects of the anti-aggregatory action of diltiazem and cordaphene in patients with ischemic heart disease].
    Leonova MV; Rumiantsev DO; Belousov IuB
    Kardiologiia; 1991 Mar; 31(3):13-6. PubMed ID: 1875587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiaggregants of thrombocytes in ischemic heart disease].
    Beloev I ; Tomov I; TŭrnovskaR
    Vutr Boles; 1985; 24(5):1-6. PubMed ID: 2868572
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of the treatment of ischemic heart disease with delayed-action verapamil].
    Zharov EI; Styrova TK; Barinov VG; Martynov AI; Galichenko IV; Sedov VP; Vertkin AL
    Klin Med (Mosk); 1991 Aug; 69(8):48-50. PubMed ID: 1791709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of essentiale forte on biosynthesis of nucleic acids and several hemodynamic parameters of the damaged myocardium in rabbits].
    Karagezian KG; Engibarian AA; Varosian MA
    Biull Eksp Biol Med; 1989 Nov; 108(11):548-50. PubMed ID: 2483823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Induced platelet aggregation in patients with coronary heart disease as well as trained and untrained control persons].
    Lehmann M; Hasler K; Hasenfuss G; Holubarsch C; Staiger A; Kasper W; Keul J
    Z Kardiol; 1985 Oct; 74(10):611-7. PubMed ID: 4072333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamics of the level of acylhydroperoxides and platelet aggregation in chronic ischemic heart disease and essential hypertension during treatment].
    Manak NA; Karoza AE
    Kardiologiia; 1986 Dec; 26(12):93-6. PubMed ID: 3560620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombocytes, lipids and hormones in arteriosclerosis and ischemic heart disease].
    Mrochek
    Kardiologiia; 1989 Sep; 29(9):102-7. PubMed ID: 2687551
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation].
    Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of lipids on thrombocyte aggregation in patients with ischemic heart disease].
    Bornikov VT; Zaĭnutdinov BR; Ishankhodzhaev TM; Saatov TS; Akmalov DM
    Kardiologiia; 1989 Jun; 29(6):22-4. PubMed ID: 2779073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relation of the aggregation of thrombocytes and their lipids to the blood plasma lipoprotein spectrum in myocardial infarct].
    Botolova EN; Solov'ev VV; Semavin IE; Ozerova IN; Polesskiĭ VA
    Klin Med (Mosk); 1986 Apr; 64(4):54-9. PubMed ID: 3724015
    [No Abstract]   [Full Text] [Related]  

  • 32. [Properties of thrombocytes in patients with ischemic heart disease].
    Sopina NV
    Vrach Delo; 1987 Apr; (4):39-41. PubMed ID: 3617634
    [No Abstract]   [Full Text] [Related]  

  • 33. [Metabolic effect of lipostabil-forte].
    Bobkova VI; Lokshina LI; Korsunskiĭ VN; Tananova GV
    Kardiologiia; 1989 Oct; 29(10):57-60. PubMed ID: 2615160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of the preparation Essenciale in chronic ischemic heart disease].
    Kukes VG; Senik EA; Gneushev ET; Potekaeva SA; Milovanova NM
    Kardiologiia; 1978 Jun; 18(6):79-82. PubMed ID: 353358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma lipid parameters in patients with alcoholic fatty liver after treatment with essential phospholipids.
    Turecky L; Kupcova V; Szantova M; Uhlikova E
    Bratisl Lek Listy; 2003; 104(7-8):227-31. PubMed ID: 15168868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of acute exertion and physical training on platelet function of the coronary patient].
    Broustet JP; Boisseau M; Bouloumie J; Emeriau JP; Bricaud H
    Arch Mal Coeur Vaiss; 1976 Mar; 69(3):305-13. PubMed ID: 828016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet aggregates in ischemic heart disease.
    Schwartz MB; Hawiger J; Timmons S; Friesinger GC
    Thromb Haemost; 1980 Jul; 43(3):185-8. PubMed ID: 7455982
    [No Abstract]   [Full Text] [Related]  

  • 38. [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].
    Skowasch D; Lentini S; Andrié R; Jabs A; Bauriedel G
    Dtsch Med Wochenschr; 2001 Jun; 126(24):707-11. PubMed ID: 11446026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of various doses of aspirin after a single and long-term administration on platelet aggregation in patients with ischemic heart disease].
    Khalfen ESh; Shvarts IL; Ivanova IA
    Kardiologiia; 1984 Jul; 24(7):74-7. PubMed ID: 6482160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and experimental study on codonopsis pilosula oral liquor in treating coronary heart disease with blood stasis].
    Xu X; Wang SR; Lin Q
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Jul; 15(7):398-400. PubMed ID: 7580058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.